Empresa Adaptive Biotechnologies Corporation
Acciones
ADPT
US00650F1093
Biotecnología e investigación médica
Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
2,6 USD | -0,38 % | +8,33 % | -46,94 % |
Resumen de negocios
Número de empleados: 709
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Minimal Residual Disease - Service
60,3
%
| 81 | 43,8 % | 103 | 60,3 % | +26,61 % |
Immune Medicine - Collaboration
25,0
%
| 66 | 35,8 % | 43 | 25,0 % | -35,86 % |
Immune Medicine - Service
14,7
%
| 32 | 17,1 % | 25 | 14,7 % | -21,46 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 185 | 100,0 % | 170 | 100,0 % | -8,11 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Harlan Robins
FOU | Founder | 51 | 08/09/09 |
Chad Robins
CEO | Chief Executive Officer | 49 | 08/09/09 |
Kyle Piskel
DFI | Director of Finance/CFO | 40 | 28/10/21 |
Julie Rubinstein
PSD | President | 52 | 01/04/11 |
Zhou Yi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Investor Relations Contact | - | - | |
Public Communications Contact | - | - | |
Stacy Taylor
LAW | General Counsel | 64 | 01/03/19 |
Sharon Benzeno
PRN | Corporate Officer/Principal | 50 | 01/09/14 |
Francis Lo
HRO | Human Resources Officer | 43 | 01/04/19 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Robert Hershberg
BRD | Director/Board Member | 61 | 01/02/13 |
Peter Neupert
BRD | Director/Board Member | 68 | 01/01/14 |
Michael Pellini
BRD | Director/Board Member | 58 | 13/02/18 |
Chad Robins
CEO | Chief Executive Officer | 49 | 08/09/09 |
Michelle Griffin
BRD | Director/Board Member | 58 | 01/03/19 |
Katey Owen
BRD | Director/Board Member | 55 | 17/03/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 145 092 271 | 140 878 850 ( 97,10 %) | 0 | 97,10 % |
Información de la empresa
Adaptive Biotechnologies Corp.
1165 Eastlake Avenue East
98109, Seattle
+206 659 0067
http://www.adaptivebiotech.comSector
Ventas por actividad
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-46,94 % | 383 M | |
-20,45 % | 10,82 mil M | |
+43,17 % | 3251,13 M | |
-35,86 % | 2114,71 M | |
-17,21 % | 2080,91 M | |
-29,81 % | 1476,2 M | |
+17,56 % | 1021,44 M | |
-4,37 % | 733 M | |
-37,00 % | 391 M | |
+13,32 % | 332 M |
- Bolsa de valores
- Acciones
- Acción ADPT
- Empresa Adaptive Biotechnologies Corporation